Incorporation of mutations in five genes in the revised International Prognostic Scoring System can improve risk stratification in the patients with myelodysplastic syndrome

Gene mutations have not yet been included in the 2016 WHO classification and revised International Prognostic Scoring System (IPSS-R), which are now widely utilized to discriminate myelodysplastic syndrome (MDS) patients regarding risk of leukemia evolution and overall survival (OS). In this study,...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Blood Cancer J
Main Authors: Hou, Hsin-An, Tsai, Cheng-Hong, Lin, Chien-Chin, Chou, Wen-Chien, Kuo, Yuan-Yeh, Liu, Chieh-Yu, Tseng, Mei-Hsuan, Peng, Yen-Ling, Liu, Ming-Chih, Liu, Chia-Wen, Liao, Xiu-Wen, Lin, Liang-In, Yao, Ming, Tang, Jih-Luh, Tien, Hwei-Fang
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group UK 2018
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5884776/
https://ncbi.nlm.nih.gov/pubmed/29618722
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41408-018-0074-7
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados